Question 1

Has Manish Agrawal received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,387,064 in general payments to Manish Agrawal across 1,806 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Manish Agrawal did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Manish Agrawal come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	8	$304,809
Eisai Inc.	1,360	$280,603
Merck	233	$278,257
EMD Serono, Inc.	129	$240,993
Pfizer	6	$107,771
Genentech, Inc.	32	$97,126
Janssen Research & Development, LLC	34	$42,499
Bayer	2	$28,894
Novartis	1	$6,100
Gilead	1	$12

Manish Agrawal

Payments from drug & device makers

Who reported the general payments

How this compares

Other hematology & oncology in Rockville